BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37855303)

  • 1. Variolin B from sea sponge against lung cancer: a multitargeted molecular docking with fingerprinting and molecular dynamics simulation study.
    Alsalmi O; Mashraqi MM; Alshamrani S; Almasoudi HH; Alharthi AA; Gharib AF
    J Biomol Struct Dyn; 2024 Apr; 42(7):3507-3519. PubMed ID: 37855303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study.
    Almasoudi HH; Mashraqi MM; Alshamrani S; Alsalmi O; Alharthi AA; Gharib AF
    J Biomol Struct Dyn; 2024; 42(1):11-21. PubMed ID: 37771142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and
    Ahmad S; Singh V; Gautam HK; Raza K
    J Biomol Struct Dyn; 2024 Mar; 42(5):2494-2511. PubMed ID: 37154501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study.
    Ahmad S; Raza K
    Mol Divers; 2023 Apr; ():. PubMed ID: 37058176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer.
    Binshaya AS; Alkahtani OS; Aldakheel FM; Hjazi A; Almasoudi HH
    Med Oncol; 2024 Mar; 41(5):101. PubMed ID: 38546811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations.
    Hakami MA; Hazazi A; Albloui F; Gharib AF; Alsaeedi FA; Abdulaziz O; Alhazmi AY; Alsaiari AA
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study.
    Alghamdi S; Baeissa HM; Azhar Kamal M; Rafeeq MM; Al Zahrani A; Maslum AA; Hakeem IJ; Alazragi RS; Alam Q
    J Biomol Struct Dyn; 2023 Aug; ():1-13. PubMed ID: 37599470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study.
    Alshehri MA; Asiri SA; Alzahrani A; Alazragi RS; Alqahtani LS; Alqosaibi AI; Alnamshan MM; Alam Q; Rafeeq MM
    Med Oncol; 2023 Oct; 40(11):337. PubMed ID: 37864019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular docking, ADMET and molecular dynamics simulation revealed metralindole as a multitargeted inhibitor for division kinases.
    Al-Dhuayan I; ALaqeel NK
    Braz J Biol; 2023; 83():e271688. PubMed ID: 37075433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.
    Almasoudi HH; Nahari MH; Alhazmi AYM; Almasabi SHA; Al-Mansour FSH; Hakami MA
    PLoS One; 2023; 18(12):e0295714. PubMed ID: 38100507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone 2HCl's adroit activity against cervical cancer replication and maintenance proteins: a multitargeted approach.
    Hakami MA; Hazazi A; Alsulami MO; Alsaiari AA
    J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38517073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.
    Almasoudi HH; Hakami MA; Alhazmi AY; Makkawi M; Alasmari S; Alghamdi YS; Mashraqi MM
    Med Oncol; 2023 Jul; 40(8):218. PubMed ID: 37394519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach.
    Alsaiari AA; Gharib AF; Bakhuraysah MM; Alrehaili AA; Algethami SM; Alsaif HA; Al Harthi N; Hakami MA
    Med Oncol; 2024 Apr; 41(5):117. PubMed ID: 38630325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential inhibitors against
    Gaur V; Kumar N; Vyas A; Chowdhury D; Singh J; Bera S
    J Biomol Struct Dyn; 2023 Dec; ():1-11. PubMed ID: 38149858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking, molecular dynamics simulation, and MM/PBSA analysis of ginger phytocompounds as a potential inhibitor of AcrB for treating multidrug-resistant
    Sahoo M; Behera DU; Gaur M; Subudhi E
    J Biomol Struct Dyn; 2024 Jan; ():1-17. PubMed ID: 38165647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor.
    Almasoudi HH; Mashraqi MM; Alshamrani SA; Alharthi AA; Alsalmi O; Nahari MH; Al-Mansour FSH; Alhazmi AYM
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical Cancer.
    Ahmad S; Sayeed S; Bano N; Sheikh K; Raza K
    J Biomol Struct Dyn; 2023 Nov; 41(19):9770-9786. PubMed ID: 36379678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches.
    Ala C; Joshi RP; Gupta P; Ramalingam S; Sankaranarayanan M
    J Biomol Struct Dyn; 2024; 42(1):261-273. PubMed ID: 37061929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
    Purohit P; Barik D; Agasti S; Panda M; Meher BR
    J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.